UCB has appointed Steve Arnold as managing director for Great Britain and Ireland.
Arnold (pictured) joins the biopharmaceutical company from Gilead Sciences, where he was general manager of their operations in Canada.
During his time at Gilead, Arnold was responsible for establishing functions such as market access, commercial operations and hiring talent.
Prior to this, he served as sales and marketing director for Gilead in the UK and Ireland and was business unit manager at Lundbeck.
Commenting on his new appointment Arnold said: “I am excited to be joining such a dynamic organisation and I relish the opportunity to further UCB’s focus of putting patients at the core of our operations.”
Steve replaces Matthew Speers who left UCB in April to form his own company Speers & Co, which will provide strategic advice and consultancy services to the healthcare sector.